Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Stopping Tumor Necrosis Factor-Alpha Inhibitors in Rheumatoid Arthritis (STARA) Clinical Trial

NCT01793519 is registered in ClinicalTrials.gov with Georgetown University as lead sponsor.

NCT NCT01793519
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01793519 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Stopping Tumor Necrosis Factor-Alpha Inhibitors in Rheumatoid Arthritis (STARA) Clinical Trial
Lead sponsor
Georgetown University
Phase
Phase 4
Overall status
Unknown status
Start date
January 31, 2013
Completion date
August 30, 2024
Enrollment
290 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis